These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Drug therapies to prevent coronary plaque rupture and erosion: present and future. Kovanen PT; Mäyranpää M; Lindstedt KA Handb Exp Pharmacol; 2005; (170):745-76. PubMed ID: 16596822 [TBL] [Abstract][Full Text] [Related]
34. Elucidation of the role of plaque instability and rupture in acute coronary events. Fuster V Am J Cardiol; 1995 Sep; 76(9):24C-33C. PubMed ID: 7572683 [TBL] [Abstract][Full Text] [Related]
35. Quantitative assessment of coronary artery plaque vulnerability by high-resolution magnetic resonance imaging and computational biomechanics: a pilot study ex vivo. Zheng J; El Naqa I; Rowold FE; Pilgram TK; Woodard PK; Saffitz JE; Tang D Magn Reson Med; 2005 Dec; 54(6):1360-8. PubMed ID: 16265643 [TBL] [Abstract][Full Text] [Related]
36. From plaque biology to clinical setting. Arbustini E; Morbini P; Bello BD; Prati F; Specchia G Am Heart J; 1999 Aug; 138(2 Pt 2):S55-60. PubMed ID: 10426860 [TBL] [Abstract][Full Text] [Related]
38. What have we learned about the biology of atherosclerosis? The role of inflammation. Libby P Am J Cardiol; 2001 Oct; 88(7B):3J-6J. PubMed ID: 11595192 [TBL] [Abstract][Full Text] [Related]
39. What an interventional cardiologist should know about the pathophysiology of acute myocardial infarction. Kristensen SD; Andersen HR; Falk E Semin Interv Cardiol; 1999 Mar; 4(1):11-6. PubMed ID: 10406063 [TBL] [Abstract][Full Text] [Related]
40. Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research. Gaba P; Gersh BJ; Muller J; Narula J; Stone GW Nat Rev Cardiol; 2023 Mar; 20(3):181-196. PubMed ID: 36151312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]